N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients.

In conclusion, NAC inhibits production of factors playing a key role in the etiopathogenesis of interstitial lung diseases, thus suggesting its possible therapeutic potency in the treatment of these disorders. PMID: 20360623 [PubMed - in process] (Source: Pharmacological Reports) Source: MedWorm: Sarcoidosis Stop Suffering the Living Hell of Sarcoidosis With Natural Alternatives and Without Drugs or [...]

Share